Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-31

FDA Approved: PIRFENIDONE — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approves Apotex Corp.'s original application for pirfenidone, a generic version of the IPF treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIRFENIDONE (pirfenidone)

Snippet

ORIG AP for PIRFENIDONE (PIRFENIDONE)